Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
aclopride
- Development stage
- Unknown
- Lead developer
- Innovative Pharmaceuticals
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
**Aclopride** is a non-specific marketed product-family name used by Innovative Pharmaceuticals for multiple oral and topical formulations rather than one chemically defined drug. The range includes aceclofenac-only products, such as Aclopride 100 DT and Aclopride-SR, as well as multi-ingredient products including Aclopride-SP and Aclopride Cold. Therefore, no single active ingredient, mechanism, dosage form, route, or disease indication can be assigned to the unqualified name without a formulation suffix. ([innovativepharma.in](https://www.innovativepharma.in/product/aclopride-100-mg-dt-tablets/))
- Brand names
- Aclopride
02
Targets
PGHS-1 (Prostaglandin G/H Synthase 1)
Beyond the preview
Go deeper on aclopride.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on aclopride.